DAVENPORT & Co LLC raised its position in BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Rating) by 44.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 157,105 shares of the company’s stock after acquiring an additional 48,560 shares during the period. […]